NewEdge Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
NewEdge Advisors's ACLS Position: Q1 2026 in Review
NewEdge Advisors reduced its Axcelis (ACLS) stake by 93% in Q1 2026, selling an estimated $198K and leaving 167 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3270.
NewEdge Advisors first reported a position in ACLS in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.58M in Q2 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- NewEdge Advisors held 167 shares of Axcelis worth $15.5K as of Q1 2026.
- NewEdge Advisors sold 2,239 Axcelis shares in Q1 2026, an estimated $198K.
- Axcelis made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3270 holding.
- NewEdge Advisors first reported a position in Axcelis in Q4 2021 and has held it in 15 quarters since.
- NewEdge Advisors's Axcelis position peaked at $1.58M in Q2 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.